BioSpace News Archive

Unmatched Scope of Resources Will Identify Distinctive Disease Mechanisms in Small Patient Subgroups, Supporting Development of Custom Therapeutic Approaches [22-October-2019] NEW YORK , Oct. 22, 2019 /PRNewswire/ -- Bloomberg Philanthropies, Johns Hopkins University School of Medicine (JHUSOM), and The New York Stem Cell Foundation (NYSCF) Research Institute today

Local collection sites will provide safe, convenient and anonymous disposal of unused or expired prescription drugs

While nearly all hospitals have set cost reduction targets, results are still lagging, according to Kaufman Hall

ugai Pharmaceutical Co., Ltd., a member of the Roche Group, will extend the company’s licensed access to the Immunogenicity Screening and Protein Reengineering Interface toolkit developed by EpiVax, Inc.

National Seating & Mobility, the leading provider of complex rehabilitation, mobility and accessibility solutions, is partnering with BraunAbility, the world leader in wheelchair accessible vehicles, to educate clients about the innovative automotive solutions driving independence for individuals with disabilities nationwide.

Health Catalyst, Inc., a leading provider of data and analytics technology and services to healthcare organizations, today announced that it will release third-quarter 2019 results on Tuesday, November 12, 2019, after the market closes.

Harpoon Therapeutics, Inc. announced that an abstract regarding HPN328 for the treatment of small cell lung cancer has been accepted for poster presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.

Amgen announced that its Board of Directors declared a $1.45 per share dividend for the fourth quarter of 2019.

Ligand Pharmaceuticals Incorporated announced plans to report third quarter 2019 financial results on November 5, 2019.

Nobel laureates and world-leading thinkers to discuss health and wellbeing at free-of-charge event titled ‘Towards Health’ on Nov. 8